APLM
Price
$23.77
Change
+$0.49 (+2.10%)
Updated
Aug 21 closing price
Capitalization
70.45M
Intraday BUY SELL Signals
MGX
Price
$1.23
Change
+$0.03 (+2.50%)
Updated
Aug 21 closing price
Capitalization
46.47M
87 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs MGX

APLM vs MGX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APLM vs. MGX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (APLM: $23.77 vs. MGX: $1.23)
Brand notoriety: APLM and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 18% vs. MGX: 200%
Market capitalization -- APLM: $70.45M vs. MGX: $46.47M
APLM [@Biotechnology] is valued at $70.45M. MGX’s [@Biotechnology] market capitalization is $46.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, APLM is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 7 TA indicator(s) are bullish while MGX’s TA Score has 4 bullish TA indicator(s).

  • APLM’s TA Score: 7 bullish, 4 bearish.
  • MGX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, APLM is a better buy in the short-term than MGX.

Price Growth

APLM (@Biotechnology) experienced а +6.14% price change this week, while MGX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

MGX is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLM($70.5M) has a higher market cap than MGX($46.5M). APLM YTD gains are higher at: 27.173 vs. MGX (-24.074). APLM has higher annual earnings (EBITDA): -56.38M vs. MGX (-87.55M). APLM has less debt than MGX: APLM (4.72M) vs MGX (39.2M). MGX has higher revenues than APLM: MGX (22.3M) vs APLM (0).
APLMMGXAPLM / MGX
Capitalization70.5M46.5M152%
EBITDA-56.38M-87.55M64%
Gain YTD27.173-24.074-113%
P/E RatioN/AN/A-
Revenue022.3M-
Total CashN/A140M-
Total Debt4.72M39.2M12%
TECHNICAL ANALYSIS
Technical Analysis
APLMMGX
RSI
ODDS (%)
Bearish Trend 3 days ago
34%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
60%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
45%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signal:
Gain/Loss:
MGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMIGX22.360.24
+1.08%
FMI Global Institutional
TSONX17.580.18
+1.03%
Nuveen International Res Eq R6
CMNWX91.480.45
+0.49%
Principal Capital Appreciation A
RSPKX27.050.13
+0.48%
Victory RS Partners R
VSPRX16.16N/A
N/A
Voya Small Company Port R6

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with EDIT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+2.50%
EDIT - MGX
49%
Loosely correlated
+5.78%
VYGR - MGX
47%
Loosely correlated
+2.11%
RXRX - MGX
46%
Loosely correlated
+4.79%
CRBU - MGX
46%
Loosely correlated
+3.11%
PRME - MGX
44%
Loosely correlated
+4.63%
More